GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
admin By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients…
Read MoreBy Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients…
Read More